NCT06848348 2026-01-12
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Dogwood Therapeutics Inc.
Phase 2 Recruiting
Clinical Trials
13 trialsNCT04704453 2025-07-31
TEC-ORL
Institut Claudius Regaud
Phase 2 Completed
NCT06766916 2025-05-18
CRYSTAL
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Recruiting
NCT06915662 2025-04-11
Pain Outcomes After Digital Amputation Using Tulavi Allayâ„¢ Nerve Cap
Massachusetts General Hospital
Phase 2 Not yet recruiting
NCT06596122 2024-09-19
Vitamin D Supplementation in Breast Cancer Patients
Cairo University
Phase 2 Not yet recruiting
NCT05322889 2024-08-28
PrevTel
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
Phase 2 Completed
NCT00996983 2023-03-24
ZIDON
National Cancer Institute, Naples
Phase 2 Unknown
NCT02924675 2019-10-14
LYRORL
University Hospital, Lille
Phase 2 Terminated
NCT01506453 2019-06-19
TINALL
St. Jude Children's Research Hospital
Phase 2 Completed
NCT02349581 2015-01-29
PPBCS
Rigshospitalet, Denmark
Phase 2 Unknown
NCT00637975 2011-02-02
Oxycodone and Pregabalin for the Treatment of Oncological Neuropathic Pain
Associazione Progetto Oncologia UMAN.A
Phase 2 Completed
NCT00474916 2010-08-16
Neuropathic Pain in Patients With Cancer
DARA Therapeutics
Phase 2 Completed
NCT00284505 2008-12-05
Use of Thalidomide in Patients With Arachnoiditis
Washington University School of Medicine
Phase 2 Completed